Glucarpidase
(gloo-KAR-pih-dayz) This page contains brief information about glucarpidase and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
| US Brand Name(s): |  | Voraxaze |
| | ||
| | ||
| FDA Approved: | | Yes |
Glucarpidase is approved to treat:
- Toxic blood levels of the anticancer drug methotrexate. Glucarpidase is used to remove methotrexate from the body in patients whose kidneys are not working as they should.
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trials Accepting PatientsFind Clinical Trials for Glucarpidase - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
Back to Top
